Improved FIFRELIN de-excitation model for neutrino applications

The precise modeling of the de-excitation of Gd isotopes is of great interest for experimental studies of neutrinos using Gd-loaded organic liquid scintillators. The FIFRELIN code was recently used within the purposes of the STEREO experiment for the modeling of the Gd de-excitation after neutron capture in order to achieve a good control of the detection efficiency. In this work, we report on the recent additions in the FIFRELIN de-excitation model with the purpose of enhancing further the de-excitation description. Experimental transition intensities from EGAF database are now included in the FIFRELIN cascades, in order to improve the description of the higher energy part of the spectrum. Furthermore, the angular correlations between {\gamma} rays are now implemented in FIFRELIN, to account for the relative anisotropies between them. In addition, conversion electrons are now treated more precisely in the whole spectrum range, while the subsequent emission of X rays is also accounted for. The impact of the aforementioned improvements in FIFRELIN is tested by simulating neutron captures in various positions inside the STEREO detector. A repository of up-to-date FIFRELIN simulations of the Gd isotopes is made available for the community, with the possibility of expanding for other isotopes which can be suitable for different applications.Comment: Corrected typos on author names on arXiv metadat

Indirect measurements of neutron-induced reaction cross sections at storage rings

Neutron-induced reaction cross sections of unstable nuclei are essential for understanding the synthesis of heavy elements in stars. However, their measurement is very difficult due to the radioactivity of the targets involved. We propose to circumvent this problem by using for the first time the surrogate reaction method in inverse kinematics at heavy-ion storage rings. In this contribution, we describe the developments we have done to perform surrogate-reaction studies at the storage rings of GSI/FAIR. In particular, we present the first results of the proof of principle experiment, which we conducted recently at the Experimental Storage Ring (ESR)

Observation of a nuclear recoil peak at the 100 eV scale induced by neutron capture

Coherent elastic neutrino-nucleus scattering and low-mass Dark Matter detectors rely crucially on the understanding of their response to nuclear recoils. We report the first observation of a nuclear recoil peak at around 112 eV induced by neutron capture. The measurement was performed with a CaWO$_4$ cryogenic detector from the NUCLEUS experiment exposed to a $^{252}$Cf source placed in a compact moderator. The measured spectrum is found in agreement with simulations and the expected peak structure from the single-$\gamma$ de-excitation of $^{183}$W is identified with 3 $\sigma$ significance. This result demonstrates a new method for precise, in-situ, and non-intrusive calibration of low-threshold experiments

Maternal Serologic Screening to Prevent Congenital Toxoplasmosis: A Decision-Analytic Economic Model

We constructed a decision-analytic and cost-minimization model to compare monthly maternal serological screening for congenital toxoplasmosis, prenatal treatment, and post-natal follow-up and treatment according to the current French protocol, versus no systematic screening or perinatal treatment. Costs are based on published estimates of lifetime societal costs of developmental disabilities and current diagnostic and treatment costs. Probabilities are based on published results and clinical practice in the United States and France. We use sensitivity analysis to evaluate robustness of results. We find that universal monthly maternal screening for congenital toxoplasmosis with follow-up and treatment, following the French (Paris) protocol, leads to savings of $620 per child screened. Results are robust to changes in test costs, value of statistical life, seroprevalence in women of childbearing age, fetal loss due to amniocentesis, incidence of primary T. gondii infection during pregnancy, and to bivariate analysis of test costs and incidence of primary T. gondii infection. Given the parameters in this model and a maternal screening test cost of$12, screening is cost-saving for rates of congenital infection above 1 per 10,000 live births. Universal screening according to the French protocol is cost saving for the US population within broad parameters for costs and probabilities

Predictors of retinochoroiditis in children with congenital toxoplasmosis : European, prospective cohort study

OBJECTIVE. By school age, 20% of children infected with congenital toxoplasmosis will have > 1 retinochoroidal lesion. We determined which children are most at risk and whether prenatal treatment reduces the risk of retinochoroiditis to help clinicians decide about treatment and follow-up. PATIENTS AND METHODS. We prospectively studied a cohort of children with congenital toxoplasmosis identified by prenatal or neonatal screening in 6 European countries. We determined the effects of prenatal treatment and prognostic markers soon after birth on the age at first detection of retinochoroiditis. RESULTS. Of 281 children with congenital toxoplasmosis, 50 developed ocular disease, and 17 had recurrent retinochoroiditis during a median follow-up of 4.1 years. Prenatal treatment had no significant effect on the age at first or subsequent lesions. Delayed start of postnatal treatment did not increase retinochoroiditis, but the analysis lacked power. Older gestational age at maternal seroconversion was weakly associated with a reduced risk of retinochoroiditis. The presence of nonocular clinical manifestations of congenital toxoplasmosis at birth strongly predicted retinochoroiditis. For 92% (230 of 249) of children with no retinochoroiditis detected before 4 months of age, the probability of retinochoroiditis by 4 years was low, whether clinical manifestations were present or not 8.0%. CONCLUSIONS. Prenatal treatment did not significantly reduce the risk of retinochoroiditis in this European cohort. If children have no retinochoroiditis in early infancy, the low risk of subsequent ocular disease may not justify postnatal treatment and repeated ophthalmic assessments during childhood. Controlled trials are needed to address the lack of evidence for the effectiveness of postnatal treatment